My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Progyny, Inc. - Common Stock (NQ:PGNY)

26.73 +2.18 (+8.88%)

Streaming Delayed Price Updated: 12:20 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Progyny, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

5 Must-Read Analyst Questions From Progyny’s Q3 Earnings Call

November 13, 2025

Progyny’s third quarter was marked by strong top-line and profitability outperformance, which drew a positive market response. Management attributed these results to robust new client acquisition, the...

Via StockStory

Topics Earnings Workforce

3 Inflated Stocks with Warning Signs

November 12, 2025

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Via StockStory

This AT&T Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday ↗

November 12, 2025

Via Benzinga

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Why Progyny Stock Is Soaring Today ↗

November 07, 2025

Progyny generates nearly $200 million in free cash flow annually and holds over $300 million in cash, yet it has a market cap of only $1.9 billion. It could be a bargain as stock-based compensation...

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 07, 2025

Via Benzinga

PGNY Q3 Deep Dive: Product Expansion and Client Diversification Drive Momentum

November 07, 2025

Fertility benefits company Progyny (NASDAQ:PGNY) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 9.3% year on year to $313.3 million. Revenue guidance for the full...

Via StockStory

PROGYNY INC (NASDAQ:PGNY) Q3 2025 Earnings Beat Estimates and Boost Full-Year Outlook ↗

November 06, 2025

Progyny (PGNY) Q3 2025 earnings beat estimates with $313.3M in revenue and $0.45 EPS. The company raised its full-year guidance, driving a positive market reaction.

Via Chartmill

Topics Earnings

Progyny (NASDAQ:PGNY) Reports Upbeat Q3, Stock Soars

November 06, 2025

Fertility benefits company Progyny (NASDAQ:PGNY) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.3% year on year to $313.3 million. Revenue guidance for the full...

Via StockStory

Progyny (PGNY) Q3 Earnings: What To Expect

November 04, 2025

Via StockStory

Topics Artificial Intelligence

3 of Wall Street’s Favorite Stocks We Find Risky

November 02, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

3 Small-Cap Stocks with Warning Signs

October 27, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks ↗

October 22, 2025

Motley Fool analysts Karl Thiel, Rick Munarriz, and Tim Beyers offer up three stocks that face dark clouds they can see through.

Via The Motley Fool

Topics Workforce

1 Safe-and-Steady Stock with Exciting Potential and 2 We Question

October 22, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Topics Supply Chain

1 Cash-Heavy Stock to Target This Week and 2 That Underwhelm

October 20, 2025

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining...

Via StockStory

Progyny Stock Logs Best Day In 2 Months As BofA Calls Trump IVF Policy ‘Incremental Positive’ — Traders Eye More Upside ↗

October 16, 2025

Trump may potentially announce new measures to expand access to in-vitro fertilization, including guidance for employers to offer supplemental fertility insurance and steep discounts on key IVF drugs.

Via Stocktwits

Topics Government World Trade

Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions

October 14, 2025

Washington D.C. – The Federal Reserve has sent clear signals of a continued dovish pivot, with Chair Jerome Powell indicating the likelihood of two additional quarter-point interest rate cuts before...

Via MarketMinute

Topics Artificial Intelligence Bonds Credit Cards

3 Stocks Under $50 with Questionable Fundamentals

October 07, 2025

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

3 Cash-Producing Stocks We Think Twice About

October 06, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

3 Reasons to Avoid PGNY and 1 Stock to Buy Instead

October 02, 2025

Over the past six months, Progyny’s shares (currently trading at $20.90) have posted a disappointing 9.1% loss, well below the S&P 500’s 18.4% gain. This might have investors contemplating their next...

Via StockStory

Topics Stocks Supply Chain

1 Healthcare Stock with Exciting Potential and 2 We Question

September 30, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

A Healthcare Debate: Progyny vs. Hims & Hers ↗

September 26, 2025

Motley Fool analysts take a look.

Via The Motley Fool

Health Insurance Providers Stocks Q2 Results: Benchmarking Progyny (NASDAQ:PGNY)

September 15, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Progyny (NASDAQ:PGNY) and its peers.

Via StockStory

Topics Artificial Intelligence Economy Fraud

Anchored at 4%: Why the Steady 10-Year Treasury Yield is Key to Unlocking the Fed's Stimulus Power

September 15, 2025

The U.S. financial markets are currently at a critical juncture, with the stability of the 10-year Treasury yield hovering steadfastly around the 4% mark. This apparent calm in long-term borrowing...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

3 Profitable Stocks Walking a Fine Line

September 10, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Bond Yields Tumble as Investors Brace for Aggressive Fed Rate Cuts

September 08, 2025

U.S. Treasury yields have recently experienced a significant decline, with the benchmark 10-year Treasury note falling to its lowest levels since April 2025. This sharp dip in yields reflects a...

Via MarketMinute

Topics Bonds Economy Supply Chain

Why Progyny (PGNY) Stock Is Trading Lower Today

September 05, 2025

Shares of fertility benefits company Progyny (NASDAQ:PGNY) fell 5.1% in the afternoon session after a broader market downturn triggered by a surprisingly weak U.S. labor market report. The decline was...

Via StockStory

Topics Artificial Intelligence

2 Small-Cap Stocks Worth Your Attention and 1 We Brush Off

September 01, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Progyny (PGNY) Stock Trades Up, Here Is Why

August 27, 2025

Shares of fertility benefits company Progyny (NASDAQ:PGNY) jumped 3.1% in the morning session after JPMorgan raised its price target on the company's stock. JPMorgan increased its price target to $25...

Via StockStory

A Glimpse Into The Expert Outlook On Progyny Through 5 Analysts ↗

August 26, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.